Free Trial
ASX:XF1

Xref (XF1) Stock Price, News & Analysis

Xref logo

About Xref Stock (ASX:XF1)

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
854,858 shs
Average Volume
N/A
Market Capitalization
A$22.08 million
P/E Ratio
N/A
Dividend Yield
6.00%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive XF1 Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Xref and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

XF1 Stock News Headlines

Strange crypto pattern discovered by 40-person research team
Something unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary people pull consistent profits from crypto — not through luck or timing, but through a systematic approach with a documented 93% win rate.tc pixel
See More Headlines

XF1 Stock Analysis - Frequently Asked Questions

Xref Limited (ASX:XF1) issued its earnings results on Thursday, February, 28th. The company reported ($0.03) earnings per share (EPS) for the quarter. Xref had a positive trailing twelve-month return on equity of 109.91% and a negative net margin of 28.61%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Xref investors own include Neuren Pharmaceuticals (NEU), Macquarie Group (MQG), Magellan Financial Group (MFG), Medlab Clinical (MDC), FBR (FBR), Embark Early Education (EVO) and Dacian Gold (DCN).

Company Calendar

Last Earnings
2/28/2019
Today
9/19/2025

Industry, Sector and Symbol

Stock Exchange
ASX
Industry
Software - Application
Sub-Industry
N/A
Current Symbol
ASX:XF1
CIK
N/A
Fax
N/A
Employees
114
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
A($0.03)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-A$5.68 million
Net Margins
-28.61%
Pretax Margin
N/A
Return on Equity
109.91%
Return on Assets
-15.96%

Debt

Debt-to-Equity Ratio
-142.84
Current Ratio
0.49
Quick Ratio
1.05

Sales & Book Value

Annual Sales
A$19.86 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
6.25
Book Value
A($0.03) per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
189,080,000
Free Float
N/A
Market Cap
A$22.08 million
Optionable
Not Optionable
Beta
1.60
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (ASX:XF1) was last updated on 9/19/2025 by MarketBeat.com Staff
From Our Partners